Atezolizumab Safe in Advanced Urothelial Cancer Atezolizumab Safe in Advanced Urothelial Cancer

The SAUL phase 3b trial met its primary safety endpoint, but the comparative efficacy of the anti-PD-L1 agent in a broader population is still up in the air.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news